Document Detail


Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.
MedLine Citation:
PMID:  12837675     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Authors examined the effect of chronic exposure to anticholinergics in a cohort of Alzheimer disease (AD) patients. METHODS: All patients were examined annually with standard neuropsychologic tests and received the cholinesterase inhibitor donepezil hydrochloride at a dose of 10 mg/day. The study population (N=69) was divided into two groups: those receiving one or more concomitant medications with significant anticholinergic properties (N=16) and those receiving no concomitant medications with anticholinergic properties (N=53). RESULTS: At 2 years, MMSE scores were significantly worse for patients receiving anticholinergic medications than for those not on anticholinergics. CONCLUSION: Although very preliminary, these data suggest that concomitant therapy with anticholinergics may be associated with significant deleterious effects on acetylcholinesterase therapy, or, more speculatively, that chronic exposure to anticholinergics may have adverse effects on the clinical course of AD.
Authors:
Ching-ju Lu; Larry E Tune
Related Documents :
1324255 - Treatment of hiv infection: the antiretroviral nucleoside analogues. nucleoside analogu...
9305295 - Diagnosis, prophylaxis, and treatment of headaches in the athlete.
21316815 - "lest we forget you - methylene blue …"
21485945 - Preservation of evidence during pediatric organ donation: a modified thoracotomy proced...
11817855 - La partera profesional: articulating identity and cultural space for a new kind of midw...
21966045 - Sowing the seeds for a career in medicine: reflections and projections.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry     Volume:  11     ISSN:  1064-7481     ISO Abbreviation:  Am J Geriatr Psychiatry     Publication Date:    2003 Jul-Aug
Date Detail:
Created Date:  2003-07-02     Completed Date:  2003-11-12     Revised Date:  2007-07-16    
Medline Journal Info:
Nlm Unique ID:  9309609     Medline TA:  Am J Geriatr Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  458-61     Citation Subset:  IM    
Affiliation:
Department of Psychiatry at Wesley Woods Geriatric Teaching and Research Hospital, Emory University School of Medicine, Atlanta, Georgia 30329-5102, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Alzheimer Disease / drug therapy*,  psychology
Cholinesterase Inhibitors / administration & dosage,  adverse effects,  therapeutic use*
Drug Administration Schedule
Female
Humans
Indans / administration & dosage,  adverse effects,  therapeutic use*
Male
Piperidines / administration & dosage,  adverse effects,  therapeutic use*
Psychomotor Agitation / epidemiology,  etiology
Retrospective Studies
Chemical
Reg. No./Substance:
0/Cholinesterase Inhibitors; 0/Indans; 0/Piperidines; 120011-70-3/donepezil
Comments/Corrections
Comment In:
Am J Geriatr Psychiatry. 2007 Apr;15(4):357-9   [PMID:  17384320 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparing clinical practice with guideline recommendations for the treatment of depression in geriat...
Next Document:  Dementia screening: can a second administration reduce the number of false positives?